|

Low pH?
Lacking Energy?





FREE booklet
"How To Properly Implement the TumorX Protocol"

How to use TumorX Apoptosis Protocol

Enzyme Video Information








Free Catalog

|
| |
Healing Actions of Ginkgo biloba
|
|
| |
$4.32
Sample
10 Count Bottle
400mg Capsules |
$12.58
1 Month Supply
90 Count Bottle
400mg Capsules |
|
|
|
|
- Overview
- Ingredients
- Directions
- Side Effects
OverviewGinkgo biloba has been used in Traditional Chinese Medicinal to treat circulatory disorders and enhance memory. Copious peer-reviewed studies from around the world have demonstrated the mechanisms of this ancient remedy.
Laboratory studies have shown that ginkgo improves blood circulation by dilating blood vessels and reducing the stickiness of blood platelets. Ginkgo leaves contain two types of chemicals-- flavonoids and terpenoids-- believed to have potent antioxidant properties.
Healing Actions of Ginkgolide
The Biloba extracts contain: Flavonoids, Terpene lactones that also include Ginkgolides A, B, and C, Bilobalide, Quercetin and lastly Kamepferol. The Ginkgolides act as anti-allergen, anti-inflammatory and treat respiratory ailments such as Asthma. The healing power of Ginkgo Biloba also kills free radicals inside of the body. These radicals can cause the body harm by afflicting damaged cells and causing various diseases. Jacobs and Browner, 2000. Christen Y, Maixent JM. 2002 Sep;48(6):601-11
Free radicals occur naturally in the body, but as we age the mechanisms to fight them off become sluggish. This is why we need to consider other methods to fortify our bodies. Antioxidants such as those found in ginkgo can help neutralize free radicals and may reduce or even help prevent some of the damage they cause.
Used as a Medical Herb
Extracts of the leaves of Ginkgo biloba have long been used in China as a traditional medicine for various disorders of health. Ginkgo Biloba extracts are widely prescribed in Germany and France for the treatment of a range of conditions including memory and concentration problems, confusion, depression, anxiety, dizziness, tinnitus and headache. The mechanisms of action are thought to reflect the action of several components of the extract. These actions include increasing blood supply by dilating blood vessels, reducing blood viscosity, modifying neurotransmitter systems, reducing the density of oxygen, and removing free radicals. Birks J, Grimley Evans J, Van Dongen M. Ginkgo Biloba for Cognitive Impairment and Dementia (Cochrane Review) in: The Cochrane Library, Issue 1 2003. Oxford
Ginkgo biloba (50:1 leaf extract)*.......................................................................390mg
Flavone Glycosides 24%
- Bilobalide 6%
- Flavone Glycosides 24%
- Quercetin,
- Kaempferol,
- Isorhamnetin
- Terpene Lactones 6%
- Terpenoids (such as ginkgolides) improve blood flow by dilating blood vessels and reducing the stickiness of platelets. (Braquet, Etienne et al. 1985; Baudouin, Pisella et al. 1999)
- Ginkgolic Acid ,5 ppm
- Total Variations Are From 2.8– 3.4%
- Ginkgolides A
- Ginkgolides B
- Ginkgolides C
- Ascorbic Acid
- Catechin
- D-Glucaric Acid,
- Diterpene Lactones,
- Flavone Glycosides
- Flavonol
- Glucose
- Iron-Based Superoxide Dismutase,
- Kynurenic
- Organic Acids Hydroxykinurenic
- P-Hydroxybenzoic Acid,
- Proanthocyanadins
- Protocatechic
- Related Alkylphenols
- Rhamnose
- Sesquiterpenes,
- Shikimic
- Vanillic
*BioAnue Ginkgo Biloba extract is a highly purified phyto-therapeutic agent known by its clinical name as EGb 761. It comes from only one type of tree and it has been declared to be an actual living fossil. Ginkgo biloba leaf extract has been used extensively in clinical trials and contains the following nutrients as described above., Jacobs and Browner, 2000. Christen Y, Maixent JM. 2002 Sep;48(6):601-11, Coran M. H. Watanabe et al, 2001.:
This product is pure nutrition; no fillers, additives or synthetic chemicals.
The gelatin capsule complies with the requirements published in:
The United States Pharmacopoeia (USP); XXIV / National Formulary (NF) 19
The European Pharmacopoeia (EP); 3rd Edition
Kosher and Halal certified
Dosage
Dosage for ginkgo leaf extract is based upon traditional use, scientific research, expert opinion, and publications. According to the Mayo Clinic, the standard dosage for most health conditions in healthy adults is between 80 and 240mg of 50:1 standardized extract. This dosage is typically taken orally in divided doses.
For patients who have memory problems and dementia, the dosage of ginkgo is 120 to 240 mg daily, taken in two to three dosages. The dosage for patients who have tinnitus and peripheral vascular disease is no more than 160 mg per day, taken in two or three dosages. An initial period of 6 to 12 weeks is recommended to assess the effectiveness of ginkgo, although results have been seen as early as four weeks.
The studies varied in length of treatment and in the daily dose of ginkgo (120 to 240 mg). The correct dosage of ginkgo has never been formally established. While 120- and 240-mg/d doses are typical among clinical trials, animal studies have used doses of 100 mg per kg.
The Chinese have been using ginkgo to treat health conditions for thousands of years. According to the National Center for Complementary and Alternative Medicine (NCCAM), Gingko is used for/as an:
- Antioxidant
- Prevention of neurodegenerative diseases
- Cardiovascular health
- Anticancer
- Ginkgo leaf extracts have been employed for treating cerebrovascular and cardiovascular diseases for centuries because ginkgolides are highly specific and potent platelet-activating factor receptor antagonists (Hosford et al., 1990). The commercial ginkgolides are produced merely from G. biloba plants, especially from the ginkgo leaves.
Side Effects
Common Side effects:
Most adults generally tolerate ginkgo leaf extract well. Minor side effects that may disappear with continued use include nausea, headache and gastrointestinal upset, dizziness, muscle weakness, racing heart, restlessness, rash, loss of muscle tone and skin irritation around the mouth.
Taking ginkgo orally is associated with an increased risk of bleeding. Therefore, anyone suffering from a bleeding disorder, or who is taking medications or herbs known to cause bleeding, should consult a health care professional before use.
Drug Interactions and overdose:
Ginkgo biloba is used for Alzheimer's disease, intermittent claudication, and many other medicinal purposes. Ginkgo leaf extract was associated with coma in a woman with Alzheimer's disease who was also taking trazodone*. Flumazenil2 reversed the coma, suggesting that excess gamma-Aminobutyric acid (GABA) activity may have been involved. (Jellin JM, Gregory P, Batz F et al., 2001, Galluzzi S, Zanetti O, Binetti G et al 2000.).
Ginkgo flavonoids appear to have GABA agonist properties and direct activity on benzodiazepine receptors (Sasaki K, Hatta S, Haga M et al. 1999.). A theoretical mechanism for this interaction is increased metabolism of trazodone to active GABAergic metabolites, possibly by induction of the CYP3A4 isozyme.
Ginkgo and Warfarin are Incompatible
It is known that ginkgo inhibits platelet aggregation. Ginkgo's ability to decrease warfarin metabolism, is also noted in studies. Intracerebral hemorrhage was associated with recent ginkgo use in a patient stabilized on warfarin for five years (Matthews MK Jr. 1998). Combination therapy with ginkgo and warfarin are inappropriate due to its inhibition of platelet adhesion. Additional side effects have been noted including:
- Episodes of subdural hematoma
- Spontaneous hyphema
- Subarachnoid hemorrhage
The aforementioned have occurred in patients taking ginkgo alone or with aspirin or ergotamine3 (Rowin J, Lewis SL. 1996, Matthews MK Jr. 1998, Mohutsky MA, Elmer GW. 2000). The combination of ginkgo and anticoagulant drugs or drugs that inhibit platelet adhesion should be avoided.
1Trazodone is used to treat depression. Trazodone is in a class of medications called serotonin modulators. It works by increasing the amount of serotonin, a natural substance in the brain that helps maintain mental balance.
2Flumazenil is of benefit in patients who become excessively drowsy after benzodiazepines are used for either diagnostic or therapeutic procedures.
3Ergotamine has been used in clinical practice for the acute treatment of migraine for over 50 years. It has been used as an antidote in the treatment of benzodiazepine overdoses. It reverses the effects of benzodiazepines by competitive inhibition at the benzodiazepine binding site on the GABAA receptor. There are many complications that must be taken into consideration when used in the acute care setting.
Special Precautions & Warnings:
Side effects of ginkgo may include headache, nausea, gastrointestinal upset, diarrhea, dizziness, or allergic skin reactions. More severe allergic reactions have occasionally been reported.
There are some data to suggest that ginkgo can increase bleeding risk, so people who take anticoagulant drugs, have bleeding disorders, or have scheduled surgery or dental procedures should use caution and talk to a health care provider if using ginkgo.
Pregnancy and breast-feeding: Ginkgo is POSSIBLY UNSAFE when used during pregnancy. It might cause early labor or extra bleeding during delivery if used near that time. Not enough is known about the safety of using ginkgo during breast-feeding. Don’t use ginkgo if you are pregnant or breast-feeding.
Children: Ginkgo leaf extract is POSSIBLY SAFE. Some research suggests that a specific combination of ginkgo leaf extract plus American ginseng might be safe in children when used short-term. Don’t let children eat the ginkgo seed. It is UNSAFE.
Diabetes: Ginkgo might interfere with the management of diabetes. If you have diabetes, monitor your blood sugar closely.
Seizures: There is a concern that ginkgo might cause seizures. If you have ever had a seizure, don’t use ginkgo.
Infertility: Ginkgo use might interfere with getting pregnant. Discuss your use of ginkgo with your healthcare provider if you are trying to get pregnant.
Bleeding disorders: Ginkgo might make bleeding disorders worse. If you have a bleeding disorder, don’t use ginkgo.
Surgery: Ginkgo might slow blood clotting. It might cause extra bleeding during and after surgery. Stop using ginkgo at least 2 weeks before a scheduled surgery.
Ginko Interactions
- Ibuprofen interacts with GINKGO
Ginkgo can slow blood clotting. Ibuprofen can also slow blood clotting. Taking ginkgo with ibuprofen can slow blood clotting too much and increase the chance of bruising and bleeding.
- Medications that slow blood clotting (Anticoagulant / Antiplatelet drugs) interacts with GINKGO
Ginkgo can slow blood clotting. Taking ginkgo along with medications that also slow clotting might increase the chances of bruising and bleeding.
Some medications that slow blood clotting include aspirin, clopidogrel (Plavix), diclofenac (Voltaren, Cataflam, others), ibuprofen (Advil, Motrin, others), naproxen (Anaprox, Naprosyn, others), dalteparin (Fragmin), enoxaparin (Lovenox), heparin, warfarin (Coumadin), and others.
- Warfarin (Coumadin) interacts with GINKGO
Warfarin (Coumadin) is used to slow blood clotting. Ginkgo might also slow blood clotting. Taking ginkgo along with warfarin (Coumadin) might increase the chances of bruising and bleeding. Be sure to have your blood checked regularly. The dose of your warfarin (Coumadin) might need to be changed.
- Alprazolam (Xanax) interacts with GINKGO
Taking Ginkgo along with alprazolam might decrease the effects of alprazolam.
- Buspirone (BuSpar) interacts with GINKGO
Ginkgo seems to affect the brain. Buspirone (BuSpar) also affects the brain. One person felt hyper and overexcited when taking ginkgo, buspirone (BuSpar), and other medications. It is unclear if this interaction was caused by ginkgo or the other medications.
- Efavirenz (Sustiva) interacts with GINKGO
Efavirenz is used to treat HIV infection. Taking efavirenz along with ginkgo extract might decrease the effects of efavirenz. Before taking ginkgo, talk to your healthcare provider if you take medications for HIV.
- Fluoxetine (Prozac) interacts with GINKGO
Taking ginkgo along with St. John's wort, other herbs and fluoxetine (Prozac) might cause you to feel irritated, nervous, jittery, and excited. This is called hypomania. It's not known if this is a concern when just ginkgo is taken with fluoxetine (Prozac).
- Medications changed by the liver (Cytochrome P450 1A2 (CYP1A2) substrates) interacts with GINKGO
Some medications are changed and broken down by the liver. Ginkgo might decrease how quickly the liver breaks down some medications. Taking ginkgo along with some medications that are changed by the liver might increase the effects and side effects of some medications. Before taking ginkgo talk to your healthcare provider if you take any medications that are changed by the liver.
Some of these medications that are changed by the liver include clozapine (Clozaril), cyclobenzaprine (Flexeril), fluvoxamine (Luvox), haloperidol (Haldol), imipramine (Tofranil), mexiletine (Mexitil), olanzapine (Zyprexa), pentazocine (Talwin), propranolol (Inderal), tacrine (Cognex), theophylline, zileuton (Zyflo), zolmitriptan (Zomig), and others.
- Medications changed by the liver (Cytochrome P450 2C19 (CYP2C19) substrates) interacts with GINKGO
Some medications are changed and broken down by the liver. Ginkgo might increase how quickly the liver breaks down some medications. Taking ginkgo with these medications might decrease how well the medication works. Before taking ginkgo, talk to your healthcare provider if you take any medications that are changed by the liver.
Some of these medications that are changed by the liver include amitriptyline (Elavil), carisoprodol (Soma), citalopram (Celexa), diazepam (Valium), lansoprazole (Prevacid), omeprazole (Prilosec), phenytoin (Dilantin), warfarin (Coumadin), and many others.
- Medications changed by the liver (Cytochrome P450 2C9 (CYP2C9) substrates) interacts with GINKGO
Some medications are changed and broken down by the liver. Ginkgo might decrease how quickly the liver breaks down some medications. Taking ginkgo along with these medications that are change by the liver might increase the effects and side effects of your medication. Before taking ginkgo talk to your healthcare provider if you take any medications that are changed by the liver.
Some medications that are changed by this liver include amitriptyline (Elavil), diazepam (Valium), zileuton (Zyflo), celecoxib (Celebrex), diclofenac (Voltaren), fluvastatin (Lescol), glipizide (Glucotrol), ibuprofen (Advil, Motrin), irbesartan (Avapro), losartan (Cozaar), phenytoin (Dilantin), piroxicam (Feldene), tamoxifen (Nolvadex), tolbutamide (Tolinase), torsemide (Demadex), warfarin (Coumadin), and others.
- Medications changed by the liver (Cytochrome P450 2D6 (CYP2D6) substrates) interacts with GINKGO
Some medications are changed and broken down by the liver. Ginkgo might decrease how quickly the liver breaks down some medications. Taking ginkgo along with some medications that are change by the liver can increase the effects and side effects of your medication. Before taking ginkgo talk to your healthcare provider if you take any medications that are changed by the liver.
Some medications that are changed by the liver include amitriptyline (Elavil), clozapine (Clozaril), codeine, desipramine (Norpramin), donepezil (Aricept), fentanyl (Duragesic), flecainide (Tambocor), fluoxetine (Prozac), meperidine (Demerol), methadone (Dolophine), metoprolol (Lopressor, Toprol XL), olanzapine (Zyprexa), ondansetron (Zofran), tramadol (Ultram), trazodone (Desyrel), and others.
- Medications changed by the liver (Cytochrome P450 3A4 (CYP3A4) substrates) interacts with GINKGO
Some medications are changed and broken down by the liver. Ginkgo might affect how quickly the liver breaks down some medications, and lead to a variety of effects and side effects. Before taking ginkgo talk to your healthcare provider if you are taking any medications that are changed by the liver.
Some medications changed by the liver include lovastatin (Mevacor), clarithromycin (Biaxin), cyclosporine (Neoral, Sandimmune), diltiazem (Cardizem), estrogens, indinavir (Crixivan), triazolam (Halcion), and others.
- Medications for diabetes (Antidiabetes drugs) interacts with GINKGO
Diabetes medications are used to lower blood sugar. Ginkgo might increase or decrease insulin and blood sugar in people with type 2 diabetes. Taking ginkgo along with diabetes medications might decrease how well your medication works. Monitor your blood sugar closely. The dose of your diabetes medication might need to be changed.
Some medications used for diabetes include glimepiride (Amaryl), glyburide (DiaBeta, Glynase PresTab, Micronase), insulin, pioglitazone (Actos), rosiglitazone (Avandia), chlorpropamide (Diabinese), glipizide (Glucotrol), tolbutamide (Orinase), and others.
- Medications that increase the chance of having a seizure (Seizure threshold lowering drugs) interacts with GINKGO
Some medications increase the chance of having a seizure. Taking ginkgo might cause seizures in some people. Taking medications that increase the chance of having a seizure along with ginkgo might greatly increase the risk of having a seizure. Do not take ginkgo with medications that increase the chance of having a seizure.
Some medications that increase the chance of having a seizure include anesthesia (propofol, others), antiarrhythmics (mexiletine), antibiotics (amphotericin, penicillin, cephalosporins, imipenem), antidepressants (bupropion, others), antihistamines (cyproheptadine, others), immunosuppressants (cyclosporine), narcotics (fentanyl, others), stimulants (methylphenidate), theophylline, and others.
- Medications used to prevent seizures (Anticonvulsants) interacts with GINKGO
Medications used to prevent seizures affect chemicals in the brain. Ginkgo can also affect chemicals in the brain. By affecting chemicals in the brain, ginkgo might decrease the effectiveness of medications used to prevent seizures.
Some medications used to prevent seizures include phenobarbital, primidone (Mysoline), valproic acid (Depakene), gabapentin (Neurontin), carbamazepine (Tegretol), phenytoin (Dilantin), and others.
- Trazodone (Desyrel) interacts with GINKGO
Trazodone (Desyrel) affects chemicals in the brain. Ginkgo can also affect chemicals in the brain. Taking trazodone (Desyrel) along with ginkgo might cause serious side effects in the brain. One person taking trazodone and ginkgo went into a coma. Do not take ginkgo if you are taking trazodone (Desyrel).
- Hydrochlorothiazide interacts with GINKGO
Hydrochlorothiazide is used to help decrease swelling and control blood pressure. Taking hydrochlorothiazide along with ginkgo might increase blood pressure. Before taking ginkgo talk to your healthcare professional if you take medications for high blood pressure.
- Omeprazole (Prilosec) interacts with GINKGO
Omeprazole (Prilosec) is changed and broken down by the liver. Ginkgo might increase how fast the liver breaks down omeprazole (Prilosec). Taking ginkgo with omeprazole (Prilosec) might decrease how well omeprazole (Prilosec) works.
Natural Regulatory Effects of Ginkgo Biloba Extract
Ginkgo Biloba extract acts in many different situations and organs, and exerts protective effect on eurodegenerative, sensory, and vascular diseases. In all of these different domains, it has been shown to act at all levels of the organization of life: molecules, cells, tissue, entire organisms, sometimes in particular situations (related to a particular pathology or to senescence) and in humans. Although many questions remain, what stands out in the literature is the overall consistency of the data. Particularly remarkable is that EGb 761 does not exert a specific unidirectional action (activating or inhibiting) in these various domains of physiology and pathology; rather it is regulatory, helping the organism to adapt to the circumstances in which it finds itself. Christen Y, Maixent JM. 2002 Sep; 48(6):601-11
- Antioxidant
- Anticancer
- Alzheimer's
Antioxidants Antioxidants are substances that find and destroy free radicals/reactive oxygen species (compounds in the body that cause Deoxyribonucleic acid [DNA] damage). Antioxidants have also been shown to improve or prevent the development of Alzheimer's disease. DNA damage has been identified as a triggering mechanism of cancer and numerous other diseases. Reactive oxygen species have been implicated as factors in many major diseases that plague humans. The application of biochemistry shows that free radicals contribute to at least fifty major diseases including:
Alzheimer's Disease
Asthma
Atherosclerosis
Cancer
Cardiovascular disease
Cataracts
Crohn's Disease
Diabetes |
Emphysema
Heart Disease
Neurodegenerative diseases
Parkinson’s disease
Radiation Injury
Rheumatoid Arthritis
Toxic Effects of Tobacco Smoke
Toxicity of Certain Medications
Toxicity of Heavy Metals (e.g., Mercury and Lead)
Vitamin deficiency |
Inflammation, such as the destruction of joints, the synovial fluid that lubricates joints and one of its components (i.e., hyaluronic acid), as well as activation of inflammation–promoting signaling molecules called cytokines |
AntioxidantIncreasing evidence suggests that aging may be a consequence of the normal, long–term exposure to reactive oxygen species and the accumulation of oxidized, damaged molecules within the cell. This process could be likened to a lifetime of “rusting away.”
Fortunately, our bodies have a good defense system to deal with free radicals. In forms of phytochemicals such as flavonoids, vitamins, and enzymes designed to change the free radical into a non-toxic substance. Choosing fruits and vegetables that are “dark and tart” really is good for maintaining good health. We should strive daily to reach our nutritional goals with the foods we consume. Unfortunately, this is not always possible. For those who already have one of the aforementioned diseases, supplementing with flavonoids and terpenoids found in Gingko Biloba is imperative to their health.
The ginkgo leaf extract can scavenge reactive oxygen species and ferryl1 ion species. It can also enhance activities of antioxidant enzymes such as superoxide dismutase, thereby indirectly contributing as an antioxidant (DeFeudis et al. 2003).
It has been suggested that ginkgo leaf extract increases expression of mitochondial enzymes which can influence reactive oxygen species generation in the mitochondria. This is a protection against uncoupling of oxidative phosphorylation, thereby increasing Adenosine-5'-triphosphate levels and regulating energy metabolism (Janssens et al., 1995).
In comparison to other antioxidants, the ginkgo leaf extract is known to be regulatory and adaptive, either dilating or contracting blood vessels, or controlling neurochemicals or neuroendocrine indicators to the circumstances (Smith and Luo 2003).
An extract of the leaves of Ginkgo Biloba has been shown to exhibit a variety of pharmacological actions. The leaf extract acts as a scavenger of reactive oxygen species hence suppressing oxidation of Low-density lipoprotein (LDL) (Maitra et al., 1995; Yan et al., 1995) and cellular lipids (Rong et al., 1996).
Suppresses Blood Platelet Aggregation
The leaf extract suppresses platelet aggregation induced by tert-butyl hydroperoxide and hydrogen peroxide through its antioxidant action (Akiba et al., 1998). Furthermore, the extract and its ingredients exhibit an antagonistic effect on platelet-activating factor (Lamant et al., 1987), and inhibitory effects on the expression of inducible nitric oxide synthase as well as nitric oxide production (Kobuchi et al., 1997; Cheung et al., 1999; 2001).
Beneficial in Cardiovascular, Cerebrovascular, and Neurological Disorders
They also exhibit protective effects on tissue abnormalities that include myocardial ischemia–reperfusion injury (Shen et al., 1998), ischemic brain damage (Zhang et al., 2000), and neuronal apoptosis (Ahlemeyer et al., 1999). These effects are supposed to be beneficial in cardiovascular, cerebrovascular, and neurological disorders (DeFeudis, 1991; Yoshikawa et al., 1999).
Oxidative Stress Ginkgo leaf extract is known to exhibit a chemopreventive action at various levels with antioxidant, antiangiogenic properties, and influence gene expression (Sagar and others 2006). The Ginkgo leaf extract’s antioxidant ability contributes to improving cellular tolerance to oxidative stress (Smith and Luo 2004) as well as to reduce angiogenesis, which is blood vessel formation required for tumor metastasis (Monte and others 1994; DeFeudis and others 2003; Kim and others 2006; Sagar and others 2006). The nitric oxide (NO) involved in cancer progression also appears to be resolved through the terpenoids of the Ginkgo leaf extract by altering the expression of NO synthase enzymes (DeFeudis and others 2003). In addition, Ginkgo leaf extract is known to influence the expression of genes involved in cell proliferation, cell differentiation, and apoptosis at the mRNA levels in breast and bladder cancer models (Gohil and others 2000; Papadopoulos and others 2000; DeFeudis and others 2003), thus providing anticancer effects.
Oxidized metal Oxides
Laurent Deguillaume et al 2005: The oxidation of organic substrates catalyzed both by the iron(II) and the hydrogen peroxide is called the ‘‘Fenton chemistry’’, on the basis of the article of Fenton (1894) which deals with the acid tartaric oxidation in the presence of H2O2 and iron(II). The Fenton reaction can contribute, in a significant amount, to the production of Oxygen-Hydrogen (OH) radicals although its reaction rate is weak (about 50 M_1 s_1 at 25 _C, Dunford, 2002).
However, the importance of the Fenton reaction in the production of OH radicals in solution is still subject to controversy. Whereas mechanisms of hydrogen peroxide decomposition and OH generation in the presence of iron is not completely understood, the studies which examine the Fenton chemistry all agree on the observations of the evolution of the mixture:
• When hydrogen peroxide is in excess compared to iron(II), an oxygen production and an iron(II) regeneration are observed;
• When iron(II) is in excess compared to hydrogen peroxide, one observes an iron(III) production and no oxygen production.
How Does Oxidized LDL Occur?The oxidation of LDL occurs when the LDL particles react with free radicals. The oxidized LDL itself then becomes more reactive with the surrounding tissues, which can produce tissue damage. Lifestyle toxicity substances like tobacco smoke, certain medications, heavy metals (e.g., mercury and lead) contribute to the formation of oxidized LDL/free radicals. Another source to consider is the foods one eats-- foods high in trans-fats. Trans-fat are an artificial unsaturated fat which contains trans-isomer fatty acids. Trans-fats are created when unsaturated fats such as vegetable oil are hydrogenated in order to create a more solid fat, such as margarine. Only unsaturated fats can be trans-fat, since only a double bond can be locked to these orientations. Saturated fatty acids are never called trans-fats because they have no double bonds, and, therefore, all their bonds are freely rotatable.Once LDL becomes oxidized, it goes directly within the inner-lining (endothelium) of any artery in the body, including the carotid artery, coronary artery or the arteries that supply your legs and arms with blood. Once there, it encourages the accumulation of inflammatory cells, such as macrophage, and platelets at the site of the vessel and promotes their adhesion to the damaged area. More macrophages, cholesterol and other lipids begin to accumulate at the site, forming a plaque that begins to grow thicker. Over time, this can slow -- or completely restrict -- the amount of blood flow that travels to one or more areas of the body.
This can result in a variety of health conditions, including Alzheimer's Disease, Cancer, Coronary Heart Disease, Diabetes, Infertility, Liver Disease, Obesity, peripheral vascular disease, and vascular dementia-- just to name a few.
Anticancer
In 2006, Bin Ye examined epidemiological data regarding effects of commonly used herbal supplements on risk for ovarian cancer and sought supporting biological evidence. Four point two percent (4.2%) of 721 controls compared to 1.6% of 668 cases regularly used Ginkgo biloba for an estimated relative risk (and 95% confidence interval) of 0.41 (0.20, 0.84) (p = 0.01); and the effect was most apparent in women with non-mucinous types of ovarian cancer, RR = 0.33 (0.15, 0.74) (p = 0.007). Petri dish experiments with normal and ovarian cancer cells showed that Ginkgo extract has significant anti-proliferative effects (40%) in serous ovarian cancer cells, but little effect in mucinous (RMUG-L) cells.
For the ginkgolides, the inhibitory effect appeared to be cell cycle blockage at G0/G1 to S phase. This combined epidemiological and biological data provide supportive evidence for further studies of the chemopreventive or therapeutic effects of Ginkgo and ginkgolides on ovarian cancer.
Alzheimer’s Disease and Neurodegenerative Diseases
Dosage:120 to 240 mg daily
For patients who have memory problems and dementia, the dosage of ginkgo is 120 to 240 mg daily, taken in two to three dosages.
Julie Vining Smith and Yuan Luo employed both Petri dishand living organismmodels displaying endogenous Aβ [Amyloid beta (Aβ) is a peptide that appears to be the main constituent of amyloid plaques (deposits found in the brains of patients with Alzheimer's disease)]production to study the effects of Aβ on intracellular free radical levels. They employed a neuroblastoma cell line stably expressing an Alzheimer’s Disease-associated double mutation, which exhibits both increased secretion and intracellular accumulation of Aβ when stimulated. A rise in levels of hydrogen peroxide (H2O2) was observed in both the Petri dish model and the living organism,Alzheimer’s Disease-associated transgenic model expressing the Aβ peptide compared with the wild type controls. Treatment of the cells with Ginkgo biloba extract significantly attenuated the basal as well as the induced levels of H2O2-related reactive oxygen species.
In 2004, Yao et al. stated that ginkgo leaf extract is known to inhibit the formation of Aβ from β-amyloid precursor protein. Aβ is a polypeptide with 39 to 43 amino acid residues and a major component of senile plaques and vascular amyloid deposits of the brains of patients suffering from Alzheimer’s disease.
The ginkgo leaf extract inhibits reactive oxygen species accumulation induced by Aβ and also reduces neuron apoptosis (organized cell death), where apoptosis is considered to be one of the main causes for neurodegenerative diseases, and thus helps to relieve Alzheimer’s disease. (Bastianetto et al. 2000)
Ginkgo Inhibited Amyloid Beta Aggregation
Watanabe et al. (2001) defined the transcriptional effects in the cortex and hippocampus of mice whose diets were supplemented with the ginkgo leaf extract. Gene expression analysis focused on the mRNAs1 that showed a more than 3-fold change in their expression. In the cortex, mRNAs for neuronal tyrosineythreonine phosphatase 1, and microtubule associated were significantly enhanced. Hyperphosphorylated2 is the major component of the neurofibrillary tangles in the brains of Alzheimer’s disease patients. The expression of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-2, calcium and chloride channels, prolactin, and growth hormone (GH), all of which are associated with brain function, were also up-regulated. In the hippocampus, only transthyretin mRNA was upregulated. Transthyretin plays a role in hormone transport in the brain and possibly a neuroprotective role by amyloid-β sequestration. This study reveals that diets supplemented with Ginkgo biloba extract have notable neuromodulatory effects in humansand illustrates the utility of genome-wide expression monitoring to investigate the biological actions of complex extracts.
Substantial evidence suggests that the accumulation of β-amyloid (Aβ)-derived peptides, and to lesser extent free radicals, may contribute to the progression of Alzheimer’s disease. In 2000, Bastianetto et al. investigated the effectiveness of ginkgo extract against toxicity induced by Aβ-derived peptides on hippocampal primary cultured cells. A co-treatment with ginkgo extract protected hippocampal neurons against toxicity induced by Aβ fragments. Ginkgo extract completely blocked Aβ-induced events, e.g. reactive oxygen species accumulation and apoptosis. These results suggest that the neuroprotective effects of Ginkgo extract are partly associated with its antioxidant properties and highlight its possible effectiveness in neurodegenerative diseases.
Substantial evidence indicates that ginkgo has neuroprotective effects. Research in Yuan Luo’s laboratory focuses on understanding mechanisms of action of the components of Ginkgo leaf extract in protection against Alzheimer's disease. Luo has demonstrated that Ginkgo inhibited amyloid beta aggregation in vitro and attenuates reactive oxidative species. These findings suggest that Ginkgo has a clear therapeutic potential for prevention and/or treatment of Alzheimer's disease.
1mRNA
Messenger Ribonucleic acid (mRNA) is a molecule of Ribonucleic acid (RNA) encoding a chemical "blueprint" for a protein product. mRNA is transcribed from a Deoxyribonucleic acid (DNA) template.
hyperPhosphorylation (the addition of phosphate groups) of proteins is a post-translational modification that is used to regulate a large number of pathways in the cell. Protein phosphorylation is essential and necessary to control the function of proteins, however sometimes this phosphorylation becomes unregulated. Many human diseases arise from the unregulated phosphorylation of key proteins, and many neurodegenerative disorders are characterised by the presence of excessively phosphorylated proteins. In particular, the tauopathies,of which Alzheimers Disease is an example, are characterized by hyperphosphorylated, insoluble aggregates of the protein tau.
Cholinesterase Inhibitors & Gingko Biloba verses Aricept
In a study of 212 subjects with Alzheimer's disease who were treated with ginkgo leaf extract, a significant overall effect was found that was comparable with the benefits of donepezil (Aricept). A review of studies of at least six months in duration demonstrated that ginkgo extract and second-generation cholinesterase inhibitors were equally effective in treating mild to moderate Alzheimer's dementia. A Cochrane meta-analysis of 33 trials concluded that ginkgo appears to be safe, and showed promising evidence of improvement of cognition and function among patients who received the herb. (Sierpina et al.)
Increased Life Span
In 2005, Yang et al. studied Ginkgo leaf and found that ginkgo improved cerebral blood flow by stimulating norepinephrine secretion and the increased the life span of mammalians treated chronically with Ginkgo.
Ginkgo Biloba Extract Verses Whole Leaf Ginkgo Powder
Ginkgo Biloba Extract from BioAnue Labs contains a minimum of 24% ginkgolides. In contrast, powdered whole leaf contains only 0.06% ginkgolides. Ginkgolides is believed to be one of the most important nutrients found in Ginkgo extract Van (Beek et al., 1991), (Zhihua Liao et al 2003). Ginkgolides are specific inhibitors of the lipid-mediator platelet aggregating factor (Braquet and Hosford, 1991; Hu et al., 1999). Recently, the ginkgolides have been reported to be selective and potent blockers of glycine receptors (Chatterjee et al., 2003; Ivic et al., 2003; Kondratskaya et al., 2002).
Scientific literature indicates the interaction of ginkgolides with GABA (gamma-amino butyric acid) receptors. GABA is an amino acid that supports the transmission of nerve impulses between the cells in the brain. Ginkgolides A and B shortened the sleeping time induced by barbiturates in mice (Brochet et al., 1999; Wada et al., 1993).
The ginkgolides have been shown to displace t-butylphosphorothionate TBPS from its binding site (Chatterjee et al., 2002, 2003), suggesting interaction with the picrotoxinin site of GABAA receptors. A recent report showed that ginkgolide B was a blocker of GABAA receptors on rat cortical slices (Ivic et al., 2003).
- Cardiovascular Benefits
- Raynaud’s Phenomenon
- Memory
Cardiovascular Benefits
Dosage:160 mg per day
The dosage for patients who have tinnitus and peripheral vascular disease is no more than 160 mg per day, taken in two or three doses.
Pietri et al (1997) showed that consumption of Ginkgo leaf extract prior to cardiac surgery helped in reducing reperfusion induced lipid peroxidation and prevented ascorbate depletion, tissue necrosis, and cardiac dysfunction. Moreover, they also showed that ginkgo reduces 50% to 60% of the postischemic production of ROS . The Ginkgo leaf extract is also known to improve coronary blood flow through antiplatelet activity and by improving contractile functions which are due to increased release of catecholamines from endogenous liver tissue reserves by flavonoids (Mahady 2002).
A study by Akiba et al. in 2004, suggests that Ginkgo leaf extract suppresses Sp-1 dependent fibronectin production in response to oxLDL, through impairment of ROS generation in mammalian mesangial cells. The effects of the extract may be beneficial in hyperlipidemia and ROS-dependent progression of glomerular damage.
Raynaud’s Phenomenon
Dosage: 360 mg/day reduction of 56%.
Raynaud’s phenomenon (RP) is a common and painful condition characterized by episodic digital ischaemia produced by emotion and cold. Treatment of RP is notoriously difficult because of the high incidence of side effects. The aim of Muir’s study was to investigate the clinical efficacy of Ginkgo leaf extract in the treatment of RP in patients with no apparent, associated condition.
A two-week assessment period was done during which patients were asked to record frequency, severity and duration of attacks in diaries. Subjects were then randomized independently of the study center to receive either active or placebo treatment for 10 weeks, during which time the same data were recorded in their diaries. Patients were seen after two and four weeks of treatment and at the end of the 10-week treatment phase. Blood samples pre- and post-treatment were taken for haemorrheology. The number of attacks per week prior to treatment with the ginkgo extract (360 mg/day) was 13.2 ± 16.5 reducing to 5.8 ± 8.3, a reduction of 56%.
Ginkgo may be effective in reducing the number of Raynaud’s attacks per week in patients suffering from Raynaud’s disease. (Muir 2002)
Memory
Dosage: 120 to 240 mg daily
For patients who have memory problems and dementia, the dosage of ginkgo is 120 to 240 mg daily, taken in two to three dosags.
Ginkgo leaf extract is known to improve memory complaints. In 2005, Walesiuk et al. used Ginkgo at a dose of 100 mg/kg and found improvements of spatial and nonspatial memory tested. Not only was Ginkgo responsible for memory response improvement but was also reported to improve response retrieval.
A major study in ginkgo’s favor was conducted by Le Bars et al in 1997. This study contributed some evidence to the memory-enhancing components of ginkgo biloba. The study assessed and compared ginkgo (120 mg/day) to placebo in Alzheimer’s disease and multi-infarct dementia. The trial took place over a 52 week period. Two hundred-two (202) patients provided data at 52 weeks. The primary outcome measures used were the Alzheimer’s disease assessment scale-cognitive subscale (ADAS-Cog), the geriatric evaluation by relative’s rating instrument (GERRI), and the clinical global impression of change. In the intent-to-treat analysis, the ginkgo group had an ADAS-Cog score 1.4 points higher than the placebo group and a GERRI score 0.14 points higher. Twenty-seven percent (27%) of patients treated with ginkgo achieved at least a 4 point improvement on the ADAS-Cog. On the GERRI, 37% of the ginkgo patients were considered to be improved. The results above led to the conclusion that ginkgo induced positive changes in cognitive performance and social functioning.
|